Back to Journals » Pharmacogenomics and Personalized Medicine
Pharmacogenomics and Personalized Medicine
ISSN: 1178-7066
An international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
We are currently seeking expressions of interest for an Associate Editor position and for Editorial Board members for this journal.
Please send your CV and a one-page vision statement detailing your overall objectives for the journal to Emi Kirilova - [email protected]. Please be sure to indicate whether you are interested in the Associate Editor role or a position on the Editorial Board in your application.
Articles:
- View all (640)
- Volume 17, 2024 (19)
- Volume 16, 2023 (97)
- Volume 15, 2022 (82)
- Volume 14, 2021 (155)
- Volume 13, 2020 (72)
- Volume 12, 2019 (34)
- Volume 11, 2018 (24)
- Volume 10, 2017 (31)
- Volume 9, 2016 (14)
- Volume 8, 2015 (16)
- Volume 7, 2014 (37)
- Volume 6, 2013 (15)
- Volume 5, 2012 (12)
- Volume 4, 2011 (10)
- Volume 3, 2010 (11)
- Volume 2, 2009 (9)
- Volume 1, 2008 (2)
Latest articles:
- 5 records -
Evaluation of CYP2C19 Genetic Variant and Its Lack of Association with Valproic Acid Plasma Concentrations Among Zhuang and Han Schizophrenia Patients in Guangxi
Teng JM, Qin S, Lu D, Gu Y, Tang SJ, Yan Q, Yao J, Zhang C
Pharmacogenomics and Personalized Medicine 2024, 17:225-236
Published Date: 14 May 2024
To Investigate the Influence of Smoking Cessation Intention and Common Downstream Variants of HDAC9 Gene on Large Artery Atherosclerotic Cerebral Infarction
Yu L, Zhao Y
Pharmacogenomics and Personalized Medicine 2024, 17:215-224
Published Date: 13 May 2024
Understanding Gene Involvement in Hepatocellular Carcinoma: Implications for Gene Therapy and Personalized Medicine
Younis MA, Harashima H
Pharmacogenomics and Personalized Medicine 2024, 17:193-213
Published Date: 7 May 2024
Association of the Reduced Function Met420del Polymorphism of SLC22A1 with Metformin-Induced Gastrointestinal Intolerance in Ethiopian Patients with Type 2 Diabetes Mellitus
Degaga A, Sirgu S, Huri HZ, Sim MS, Loganadan NK, Kebede T, Tegene B, Engidawork E, Shibeshi W
Pharmacogenomics and Personalized Medicine 2024, 17:183-191
Published Date: 3 May 2024
Three Liquid-Liquid Phase Separation-Related Genes Associated with Prognosis in Glioma
Lv L, Zhang X, Liu Y, Zhu X, Pan R, Huang L
Pharmacogenomics and Personalized Medicine 2024, 17:171-181
Published Date: 22 April 2024